Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Bi-Ostetic Bioactive Glass Foam

K-Number: K170917 · 2017-10-30

Decision Date2017-10-30
Product CodeMQV
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Bi-Ostetic Bioactive Glass Foam is a medical device manufactured by Berkeley Advanced Biomaterials. It received FDA 510(k) clearance on 2017-10-30 under approval number K170917. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Bi-Ostetic Bioactive Glass Foam?

Bi-Ostetic Bioactive Glass Foam is a medical device that received FDA 510(k) clearance on 2017-10-30. It is manufactured by Berkeley Advanced Biomaterials. The 510(k) number is K170917.

When was Bi-Ostetic Bioactive Glass Foam approved by the FDA?

Bi-Ostetic Bioactive Glass Foam received FDA 510(k) clearance on 2017-10-30, under approval number K170917.

What company makes Bi-Ostetic Bioactive Glass Foam?

Bi-Ostetic Bioactive Glass Foam is manufactured by Berkeley Advanced Biomaterials.

What is the FDA product code for Bi-Ostetic Bioactive Glass Foam?

The FDA product code for Bi-Ostetic Bioactive Glass Foam is MQV.

Related Clinical Trials

Related Devices (Code: MQV)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.